Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist.

Coltamai, L; Bucher, M; Maillard, M P; Shukla, U; Bohidar, N; Haskell, L; Bertelsen, K; Fedgchin, M; Vogt, B; Burnier, M

Coltamai, L; Bucher, M; Maillard, M P; Shukla, U; Bohidar, N; Haskell, L; Bertelsen, K; Fedgchin, M; Vogt, B; Burnier, M.

Affiliation

Coltamai L; Department of Medicine, Division of Nephrology and Hypertension, Central University Hospital of Vaud, Lausanne, Switzerland.

Clin Pharmacol Ther ; 85(2): 145-8, 2009 Feb.

Article in En | MEDLINE | ID: mdl-18987622

Subject(s)

Antidiuretic Hormone Receptor Antagonists; Benzazepines/pharmacology; Regional Blood Flow/drug effects; Skin/blood supply; Skin/drug effects; Spiro Compounds/pharmacology; Adolescent; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Male; Receptors, Vasopressin/physiology; Regional Blood Flow/physiology; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Regional Blood Flow / Skin / Spiro Compounds / Benzazepines / Antidiuretic Hormone Receptor Antagonists Type of study: Clinical_trials Limits: Adolescent / Adult / Humans / Male Language: En Journal: Clin Pharmacol Ther Year: 2009 Document type: Article

Fulltext

XML

PubMed Links

Search on Google